MIM
GNLX icon

MetLife Investment Management’s Genelux GNLX Stock Holding History

MetLife Investment Management’s Portfolio GNLX Stock Details GNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,118
Closed -$142K – 2798
2023
Q4 		$142K Hold
10,118
– – ﹤0.01% 2426
2023
Q3 		$248K Buy
+10,118
New +$256K ﹤0.01% 2084

Other funds holding GNLX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WDC
Woodward Diversified Capital Bakersfield, California $227M AUM 40.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PWM
Provident Wealth Management Brentwood, Tennessee $331M AUM 15.75% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MetLife Investment Management's GNLX Position: Q1 2024 in Review

MetLife Investment Management sold out of Genelux (GNLX) in Q1 2024, closing a stake of 10,118 shares — an estimated $142K sold.

MetLife Investment Management first reported a position in GNLX in Q3 2023 and held it in 2 quarters. The position peaked at $248K in Q3 2023. 67 funds tracked by Wall St. Rank hold GNLX as of Q1 2024.

  • MetLife Investment Management reported no remaining Genelux position as of Q1 2024 after selling out during the quarter.
  • MetLife Investment Management sold 10,118 Genelux shares in Q1 2024, an estimated $142K.
  • MetLife Investment Management first reported a position in Genelux in Q3 2023 and held it in 2 quarters.
  • MetLife Investment Management's Genelux position peaked at $248K in Q3 2023.
  • 67 funds tracked by Wall St. Rank held Genelux as of Q1 2024.

Based on MetLife Investment Management's 13F filing for Q1 2024, filed 14 May 2024.